ChemoCentryx
CCXI
#3686
Rank
A$5.22 B
Marketcap
A$72.65
Share price
0.00%
Change (1 day)
18.93%
Change (1 year)

Market capitalization of ChemoCentryx (CCXI.defunct)

Last known market cap: A$5.22 Billion

On November 25, 2022 ChemoCentryx had a market cap of A$5.22 Billion. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of ChemoCentryx from 2012 to 2022

End of year Market Cap

Year Marketcap Change
2022A$5.49 B56.22%
2021A$3.51 B-36.89%
2020A$5.57 B63.79%
2019A$3.40 B333.76%
2018A$0.78 B111.06%
2017A$0.37 B-24.27%
2016A$0.49 B-0.11%
2015A$0.49 B35.5%
2014A$0.36 B30.24%
2013A$0.27 B-27.26%
2012A$0.38 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
A$772.57 B 14,687.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$210.39 B 3,926.94%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
A$498.22 B 9,436.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$262.10 B 4,916.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$38.59 B 638.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$393.23 B 7,426.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$168.54 B 3,126.06%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$157.64 B 2,917.28%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
A$50.30 B 862.89%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel